SSA
RGC icon

Schonfeld Strategic Advisors’s Regencell Bioscience RGC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,100
Closed -$888K – 2515
2025
Q2 		$888K Buy
+52,100
New +$635K 0.01% 1342
2021
Q4 		– Sell
-387,600
Closed -$231K – 2468
2021
Q3 		$231K Buy
+387,600
New +$175K ﹤0.01% 1693

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Schonfeld Strategic Advisors's RGC Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Regencell Bioscience (RGC) in Q3 2025, closing a stake of 52,100 shares — an estimated $888K sold.

Schonfeld Strategic Advisors first reported a position in RGC in Q3 2021 and held it in 2 quarters. The position peaked at $888K in Q2 2025. 16 funds tracked by Wall St. Rank hold RGC as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Regencell Bioscience position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 52,100 Regencell Bioscience shares in Q3 2025, an estimated $888K.
  • Schonfeld Strategic Advisors first reported a position in Regencell Bioscience in Q3 2021 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Regencell Bioscience position peaked at $888K in Q2 2025.
  • 16 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.